Headquarters
1401 HAWTHORN WAY, WESTLAKE, TX 76262-9034, US
WESTLAKE, TX, US
From the company
GenrAb is harnessing the power of human immunity to develop therapies that can protect and treat patients with neurological diseases. Its proprietary Antibody Gene Signature (AGS) technology has identified over 400 potentially therapeutic fully-human monoclonal antibodies (mAbs) to treat neurological disorders. Its lead mAb, TGM-010, targets a conserved neurodegenerative pathway and has demonstrated reduced disability in preclinical models.
1401 HAWTHORN WAY, WESTLAKE, TX 76262-9034, US
Quantities, certifications, and timing.